NeuroBo Pharmaceuticals, Inc. Appoints D. Gordon Strickland to its Board of Directors - PR Newswire -BoardProspects

NeuroBo Pharmaceuticals, Inc. Appoints D. Gordon Strickland to its Board of Directors

PR Newswire Jan 28 2022 BoardMoves

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced the appointment of D. Gordon Strickland to its Board of Directors, effective as of January 27, 2022. Mr. Strickland will serve as Chair of the Company's Audit Committee...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- NASDAQ OMX Reports Record Fourth Quarter 2013 Results also mentions Nasdaq
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- New Slate of Directors to be Proposed for Cathay Forest Products Corp. also published in PR Newswire
- Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
- Former Aes Ceo Paul Hanrahan Elected to Arch Coal's Board of Directors also published in PR Newswire
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned